Tag: tumor ablation market forecast

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Primary Drivers Are Supporting the Continued Market Growth of theTumor Ablation Market?

The growth of minimally invasive procedures is expected to drive the tumor ablation market. Minimally invasive procedures, which involve smaller incisions or no incisions, are gaining popularity due to their shorter recovery times and lower risks. Tumor ablation is used in these procedures to destroy cancerous tissues while minimizing damage to surrounding healthy tissue. Intuitive Surgical reported a 12% increase in da Vinci robotic systems in the fourth quarter of 2023. Thus, the demand for minimally invasive procedures is supporting the growth of the tumor ablation market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17283&type=smp

#How Will the CAGR of the Tumor Ablation Market Influence Its Overall Growth by 2034?

The tumor ablation market size will grow from $1.45 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. Growth is driven by the development of more precise ablation techniques, higher healthcare spending in emerging economies, an aging population, increasing cancer rates, and the global cancer burden.

The tumor ablation market is set for rapid growth, reaching $2.54 billion by 2029 with a CAGR of 11.8%. This growth is driven by the rising incidence of cancer, the growth of minimally invasive procedures, expanding applications, increasing healthcare cost-effectiveness, and greater awareness. Key trends include technological advancements, continued development of advanced ablation technologies, AI integration, focus on outpatient settings, and patient-centric approaches.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17283

How Are Consumer Market Innovations Shaping the Current and Future Landscape of theTumor Ablation Market?

In the tumor ablation market, companies are working on innovative products like bone tumor ablation systems to improve treatment efficacy. For example, in March 2024, Medtronic received FDA clearance for its OsteoCool 2.0 bone tumor ablation system, designed to treat painful bone metastases and benign bone tumors, using up to four cooled probes for simultaneous ablation of multiple vertebral bodies.

Who Are the Key Market Players Influencing the Growth of the Corn and Tumor Ablation Industry?

Major companies operating in the tumor ablation market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Varian Medical Systems Inc., Merit Medical Systems Inc., Bioventus LLC, Accuray Incorporated, AtriCure Inc., AngioDynamics Inc., EDAP TMS S.A., NeuWave Medical Inc., Mirabilis Medical Inc., STARMed Co. Ltd., Profound Medical Corp., RF Medical Co. Ltd., IceCure Medical Ltd., MedWaves Inc., Chongqing Haifu Medical Technology Co. Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/tumor-ablation-global-market-report

Which Key Market Segments Comprise the Tumor Ablation Market and Drive Its Revenue Growth?

The tumor ablation market covered in this report is segmented –

1) By Type: Thermal Ablation, Chemical Ablation

2) By Types Of Treatment: Percutaneous, Laparoscopic, Surgical

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Cancer

4) By End Users: Hospitals, Oncology Centers, Other End Users

Subsegments:

1) By Thermal Ablation: Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Cryoablation, Laser Ablation, High-Intensity Focused Ultrasound (HIFU)

2) By Chemical Ablation: Ethanol Ablation, Acetic Acid Ablation, Chemotherapy-Based Ablation (Chemoembolization)

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=17283&type=smp

Which Regions Are Emerging as Leaders in the Tumor Ablation Market?

North America was the largest region in the tumor ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Tumor Ablation Market 2025, By The Business Research Company:

Intratumoral Cancer Therapies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/intratumoral-cancer-therapies-global-market-report

Tumor Infiltrating Lymphocytes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-infiltrating-lymphocytes-global-market-report

Solid Tumor Cancer Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/solid-tumor-cancer-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 15% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the tumor ablation market?

The market size for tumor ablation has seen a swift growth in the last few years. Projected to surge from a value of $1.45 billion in 2024, to reach $1.62 billion in 2025, this market will experience a compound annual growth rate (CAGR) of 12.1%. Factors fueling the growth during the historical phase include the creation of better and more effective ablation methods, increased healthcare spending in emerging economies, a demographic trend towards aging populations, a growing cancer burden, and an escalating global prevalence of cancer.

What will be the tumor ablation market size in the future?

Predictions indicate a swift expansion of the tumor ablation market in the coming years, with its value projected to reach $2.54 billion in 2029, growing at a compound annual growth rate (CAGR) of 11.8%. This predicted surge over the forecast period can be associated with factors such as a rise in cancer cases, the proliferation of minimally invasive procedures, broadening applications, better cost-effectiveness in healthcare, and increased levels of awareness and education. Furthermore, key trends over the forecast period include technological innovation, ongoing advancements in ablation technologies, AI integration, an emphasis on outpatient settings, and patient-centered strategies.

Get your tumor ablation market report here!

https://www.thebusinessresearchcompany.com/report/tumor-ablation-global-market-report

What main drivers are fueling expansion in the tumor ablation market?

The tumor ablation market’s growth is anticipated to be fueled by the proliferation of minimally invasive procedures. These procedures, which require small or no incisions, are becoming increasingly popular due to their lesser recovery times, reduced incidence of complications and pain post-operation compared to conventional surgeries. Tumor ablation is employed in these procedures to eliminate cancerous tissues using methods like radiofrequency, microwave, or cryoablation. This limits damage to the surrounding healthy tissues and speeds up recovery. For example, in the fourth quarter of 2023, Intuitive Surgical Inc., a US-based manufacturer of robotic products, reported a placement of 415 da Vinci surgical systems (robotics using a minimally invasive surgical strategy), marking a 12% increase from 2022. As such, the rise of minimally invasive procedures is propelling the tumor ablation market’s growth.

What key areas define the segmentation of the global tumor ablation market?

The tumor ablation market covered in this report is segmented –

1) By Type: Thermal Ablation, Chemical Ablation

2) By Types Of Treatment: Percutaneous, Laparoscopic, Surgical

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Cancer

4) By End Users: Hospitals, Oncology Centers, Other End Users

Subsegments:

1) By Thermal Ablation: Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Cryoablation, Laser Ablation, High-Intensity Focused Ultrasound (HIFU)

2) By Chemical Ablation: Ethanol Ablation, Acetic Acid Ablation, Chemotherapy-Based Ablation (Chemoembolization)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17283&type=smp

What are the top market players propelling the growth of the tumor ablation industry?

Major companies operating in the tumor ablation market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Varian Medical Systems Inc., Merit Medical Systems Inc., Bioventus LLC, Accuray Incorporated, AtriCure Inc., AngioDynamics Inc., EDAP TMS S.A., NeuWave Medical Inc., Mirabilis Medical Inc., STARMed Co. Ltd., Profound Medical Corp., RF Medical Co. Ltd., IceCure Medical Ltd., MedWaves Inc., Chongqing Haifu Medical Technology Co. Ltd.

What emerging trends are influencing the growth of the tumor ablation market?

Leading enterprises in the tumor ablation market are pioneering advanced products, like bone tumor ablation systems, to boost treatment effectiveness, enhance patient results, and widen the spectrum of treatable tumors. A system for ablating bone tumors is a sophisticated medical apparatus utilized for addressing bone tumors via minimally invasive methods. For example, in March 2024, Medtronic plc, a medical device company from Ireland, obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its OsteoCool 2.0 bone tumor ablation system. This advanced system is crafted to attend to painful bone metastases and benign bone tumors such as osteoid osteoma. The OsteoCool 2.0 has the capacity for the concurrent use of four internally cooled probes, granting doctors the ability to eliminate two vertebral bodies concurrently or create larger elimination zones in extra-spinal applications. It delivers 20W per channel, which is more than double the power of the Stryker OptaBlate bone tumor ablation system.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17283

Which regions are most influential in expanding the tumor ablation market?

North America was the largest region in the tumor ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Intratumoral Cancer Therapies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/intratumoral-cancer-therapies-global-market-report

Tumor Infiltrating Lymphocytes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-infiltrating-lymphocytes-global-market-report

Solid Tumor Cancer Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/solid-tumor-cancer-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What CAGR Will the Tumor Ablation Market Achieve During 2025–2034, and What Does It Indicate?

There has been a rapid expansion in the size of the tumor ablation market in the recent past. The market which was valued at $1.45 billion in 2024, is projected to increase by 12.1% compound annual growth rate (CAGR), reaching a value of $1.62 billion in 2025. Factors that have contributed to this significant growth in the past include advancements in ablation technology that is more precise and efficient, a noted increase in healthcare spending in developing economies, a demographic trend favoring older populations, growing cancer rates, and an overall global surge in cancer prevalence.

The market size of tumor ablation is projected to experience swift expansion in the upcoming years, escalating to $2.54 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 11.8%. Factors contributing to this growth during the predicted period include a rise in cancer occurrence, growth in minimally invasive techniques, broadening applications, improved effectiveness of healthcare costs, and enhanced awareness and education. The forecasting period will be defined by significant trends such as progress in technology, persistent evolution of advanced ablation technologies, integration of artificial intelligence, emphasis on outpatient care settings, and patient-oriented strategies.

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Tumor Ablation Market?

The surge in minimally invasive procedures is anticipated to spur the progression of the tumor ablation market. These procedures, which necessitate small or no incisions, are gaining in popularity due to their shortened recovery time, reduced risk of complications, and less post-operative discomfort compared to regular surgeries. Tumor ablation forms part of these procedures by eliminating cancerous tissues via methods such as radiofrequency, microwave, or cryoablation, with minimal damage to the nearby healthy tissues and further shortening of recovery duration. For example, in January 2024, Intuitive Surgical Inc., producing robotic items in the US, stated that they had positioned 415 da Vinci surgical systems (robotic surgical systems adopting a minimally invasive surgical method) in the final quarter of 2023, demonstrating a 12% rise compared to 2022. Therefore, the rise in minimally invasive procedures demonstrates a contributing factor to the market growth of tumor ablation.

Explore Comprehensive Insights Into The Global Tumor Ablation Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17283&type=smp

Who Are the Key Firms Paving the Way for Growth in the Tumor Ablation Market?

Major companies operating in the tumor ablation market are:

• Abbott Laboratories

• Medtronic plc

• Siemens Healthineers AG

• Stryker Corporation

• Boston Scientific Corporation

What Are the Most Influential Trends Currently Shaping the Tumor Ablation Market?

Leading firms in the tumor ablation market are working on cutting-edge products like bone tumor ablation systems to increase treatment efficiency, boost patient results, and accommodate more types of tumors. The bone tumor ablation system is a distinct medical instrument used for treating bone tumors using minor surgical procedures. For example, in March 2024, Medtronic plc, a medical device firm based in Ireland, acquired U.S. Food and Drug Administration (FDA) 510(k) clearance for its OsteoCool 2.0 bone tumor ablation system. This advanced system is engineered to treat painful bone metastases and benign bone tumors such as osteoid osteoma. The OsteoCool 2.0 has the capacity for the concurrent use of four internally cooled probes, allowing doctors to ablate two vertebral bodies concurrently or create larger ablation areas in non-spinal applications. With a delivery of 20W per channel, it has over double the power of the Stryker OptaBlate bone tumor ablation system.

Secure Your Global Tumor Ablation Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/tumor-ablation-global-market-report

Which Primary Segments of the Tumor Ablation Market Are Driving Growth and Industry Transformations?

The tumor ablation market covered in this report is segmented –

1) By Type: Thermal Ablation, Chemical Ablation

2) By Types Of Treatment: Percutaneous, Laparoscopic, Surgical

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Cancer

4) By End Users: Hospitals, Oncology Centers, Other End Users

Subsegments:

1) By Thermal Ablation: Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Cryoablation, Laser Ablation, High-Intensity Focused Ultrasound (HIFU)

2) By Chemical Ablation: Ethanol Ablation, Acetic Acid Ablation, Chemotherapy-Based Ablation (Chemoembolization)

Which Regions Are Essential for the Growth of the Tumor Ablation Market?

North America was the largest region in the tumor ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Definition of the Tumor Ablation Market Impacting Future Growth?

Tumor ablation is a minimally invasive medical procedure used to destroy cancerous tissues. It involves the application of extreme heat, cold, or chemical agents directly to the tumor, causing cell death. This technique is often employed for small tumors or those in difficult-to-reach locations.

Browse Through More Similar Reports By The Business Research Company:

Intratumoral Cancer Therapies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/intratumoral-cancer-therapies-global-market-report

Tumor Infiltrating Lymphocytes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-infiltrating-lymphocytes-global-market-report

Solid Tumor Cancer Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/solid-tumor-cancer-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: